Identification of carboxymethyl (CM)-binding proteins derived from Lolium multiflorum pollen extract and antibody reactivity in Brazilian allergic patients.


Journal

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas
ISSN: 1414-431X
Titre abrégé: Braz J Med Biol Res
Pays: Brazil
ID NLM: 8112917

Informations de publication

Date de publication:
2023
Historique:
received: 19 06 2023
accepted: 18 08 2023
medline: 23 10 2023
pubmed: 18 10 2023
entrez: 18 10 2023
Statut: epublish

Résumé

Lolium multiflorum grass is the major pollen allergen source in the southern region of Brazil, but most of its allergens remain poorly characterized. The aim of this study was to investigate antibody reactivity to L. multiflorum crude and carboxymethyl-ligand extracts in allergic patients and healthy individuals. Ion exchange carboxymethyl (CM) chromatography (CM-Sepharose) was used to isolate proteins (S2) from L. multiflorum crude extract (S1), which were assessed by SDS-PAGE. S1- and S2-specific IgE and IgG4 levels were measured by ELISA using sera from 55 atopic and 16 non-atopic subjects. Reactive polypeptide bands in S1 and S2 were detected by immunoblotting, and the most prominent bands in S2 were analyzed by mass spectrometry (MS-MS). Similar IgE and IgG4 levels were observed to both S1 (IgE median absorbance: 1.22; IgG4 median absorbance: 0.68) and S2 (IgE median absorbance: 1.26; IgG4 median absorbance: 0.85) in atopic subjects. S1 and S2 had positive correlations for IgE and IgG4 (IgE: r=0.9567; IgG4: r=0.9229; P<0.0001) levels. Homology between S1 and S2 was confirmed by IgE (84%) and IgG4 (83%) inhibition. Immunoblotting revealed that the 29-32 kDa band was recognized by 100% of atopic subjects in both S1 and S2. MS-MS analysis identified similarity profile to groups 1 and 5 grass allergens. This study revealed that carboxymethyl-ligand fraction played an important role for pollen allergy diagnosis by containing clinically relevant allergens and constituted a promising candidate for allergen-specific immunotherapy.

Identifiants

pubmed: 37851792
pii: S0100-879X2023000100670
doi: 10.1590/1414-431X2023e12957
pmc: PMC10578120
pii:
doi:

Substances chimiques

Carrier Proteins 0
Ligands 0
Immunoglobulin E 37341-29-0
Allergens 0
Immunoglobulin G 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e12957

Références

Allergol Immunopathol (Madr). 2016 Jan-Feb;44(1):18-22
pubmed: 25982581
Anal Biochem. 1976 May 7;72:248-54
pubmed: 942051
Prim Care. 2016 Sep;43(3):465-75
pubmed: 27545735
Allergy. 2017 Dec;72(12):1849-1858
pubmed: 28543717
Immunol Lett. 2017 Sep;189:19-26
pubmed: 28472641
EBioMedicine. 2019 Dec;50:421-432
pubmed: 31786130
Braz J Med Biol Res. 2010 Feb;43(2):166-75
pubmed: 20098843
Arch Bronconeumol (Engl Ed). 2019 Mar;55(3):146-155
pubmed: 30449614
Nurs Stand. 2016 Jun 22;30(43):48-53
pubmed: 27332610
Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350-4
pubmed: 388439
Braz J Otorhinolaryngol. 2006 Jul-Aug;72(4):562-7
pubmed: 17143438
J Allergy. 1962 Jan-Feb;33:84-93
pubmed: 14468977
Asian Pac J Allergy Immunol. 2019 Mar;37(1):30-35
pubmed: 29549697
Nature. 1970 Aug 15;227(5259):680-5
pubmed: 5432063
Eur J Biochem. 1999 Jul;263(1):33-40
pubmed: 10429184
Pediatr Clin North Am. 1988 Oct;35(5):995-1009
pubmed: 3050840
J Clin Invest. 1997 Apr 1;99(7):1673-81
pubmed: 9120011
Protoplasma. 2006 Aug;228(1-3):13-9
pubmed: 16937050
Int Arch Allergy Immunol. 2017;172(4):187-202
pubmed: 28467993
Homeopathy. 2016 May;105(2):202-8
pubmed: 27211328
Biomed Res Int. 2019 Jul 29;2019:9840890
pubmed: 31467923
Proteomics. 2005 Feb;5(3):729-36
pubmed: 15668999
Int Arch Allergy Immunol. 2006;140(2):121-30
pubmed: 16601349
PLoS One. 2015 Jun 11;10(6):e0128402
pubmed: 26067084
Braz J Otorhinolaryngol. 2005 Sep-Oct;71(5):590-7
pubmed: 16612519
Plant Physiol. 2003 Aug;132(4):2073-85
pubmed: 12913162
Clin Mol Allergy. 2019 Apr 02;17:6
pubmed: 30983886
Clin Rev Allergy Immunol. 2019 Apr;56(2):219-233
pubmed: 30206782
J Allergy Clin Immunol. 2019 Mar;143(3):1067-1076
pubmed: 30445057
J Investig Allergol Clin Immunol. 2009;19 Suppl 1:3-10
pubmed: 19476048
Plant Biotechnol J. 2012 Feb;10(2):184-94
pubmed: 21951299
Clin Exp Allergy. 2014 Jun;44(6):790-801
pubmed: 24684550
Mol Immunol. 2018 Aug;100:126-135
pubmed: 29778490
Int Arch Allergy Immunol. 2011;154(4):295-8
pubmed: 20962534
Allergy. 2015 Oct;70(10):1201-11
pubmed: 26186076
Mol Immunol. 2008 Dec;46(2):286-93
pubmed: 18817975
Arch Ophthalmol. 1990 Jan;108(1):84-8
pubmed: 2297337

Auteurs

A S Correa (AS)

Instituto de Ciências Biomédicas, Universidade Federal de Uberlândia, Uberlândia, MG, Brasil.

J S Miranda (JS)

Instituto de Ciências Biomédicas, Universidade Federal de Uberlândia, Uberlândia, MG, Brasil.

L A R Oliveira (LAR)

Instituto de Ciências Biomédicas, Universidade Federal de Uberlândia, Uberlândia, MG, Brasil.

P F S Moreira (PFS)

Instituto de Ciências Biomédicas, Universidade Federal de Uberlândia, Uberlândia, MG, Brasil.

F A M Vieira (FAM)

Departamento de Medicina, Universidade de Caxias do Sul, Caxias do Sul, RS, Brasil.

J P Cunha-Junior (JP)

Instituto de Ciências Biomédicas, Universidade Federal de Uberlândia, Uberlândia, MG, Brasil.

R O Resende (RO)

Instituto de Ciências Biomédicas, Universidade Federal de Uberlândia, Uberlândia, MG, Brasil.
Instituto Oswaldo Cruz, Fiocruz, Rio de Janeiro, RJ, Brasil.

E A Taketomi (EA)

Instituto de Ciências Biomédicas, Universidade Federal de Uberlândia, Uberlândia, MG, Brasil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH